# Colchicine Cardiovascular Outcomes Trial (COLCOT)

> **NCT02551094** · PHASE3 · COMPLETED · sponsor: **Montreal Heart Institute** · enrollment: 4745 (actual)

## Conditions studied

- Coronary Artery Disease
- Myocardial Infarction

## Interventions

- **DRUG:** colchicine
- **DRUG:** colchicine placebo

## Key facts

- **NCT ID:** NCT02551094
- **Lead sponsor:** Montreal Heart Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-04
- **Primary completion:** 2019-07-17
- **Final completion:** 2019-07-17
- **Target enrollment:** 4745 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02551094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02551094, "Colchicine Cardiovascular Outcomes Trial (COLCOT)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02551094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*